{"id":6889,"date":"2010-02-23T14:52:00","date_gmt":"2010-02-23T14:52:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/geez-gsk-find-another-source-of-more\/"},"modified":"2019-02-21T01:22:06","modified_gmt":"2019-02-21T01:22:06","slug":"geez-gsk-find-another-source-of-more","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/","title":{"rendered":"Geez, GSK! Find Another Source of &#8220;Balanced&#8221; Commentary"},"content":{"rendered":"<p>GSK continues to use its &#8220;More Than Medicine&#8221; blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see <a href=\"http:\/\/pharma-mkting.com\/blog\/2010\/02\/steve-nissen-to-gsk-and-fda-put.html\">Steve Nissen to GSK (and FDA): &#8220;Put Patients First! It&#8217;s Time to Pull Avandia from the Market.&#8221;<\/a>).<\/p>\n<p>In an early-evening post yesterday, blogger &#8220;Michael F&#8221;, complained of the  &#8220;misleading headlines stating that &#8216;FDA Report Advises Avandia be Pulled from the Market,'&#8221; which he noted &#8220;were re-Tweeted dozens of times.&#8221; Then he pointed out that other commentary, which GSK found to be &#8220;more balanced&#8221; gained less attention.<\/p>\n<p>Michael F cited &#8220;this piece in Forbes,&#8221; as his example of a &#8220;more balanced&#8221; account (see <a href=\"http:\/\/www.morethanmedicine.us.gsk.com\/blog\/2010\/02\/an-end-of-day-update-on-avandia-rosiglitazone.html\">here<\/a> or screen shot below in case they delete or edit the post; click for enlarged view).<\/p>\n<div class=\"separator\" style=\"clear: both; text-align: center;\"><a href=\"http:\/\/4.bp.blogspot.com\/_ZiPiXEv_Q_g\/S4Pki-9re4I\/AAAAAAAAC4E\/AsNCV19TzNc\/s1600-h\/AvandiaPost.jpg\" imageanchor=\"1\" style=\"margin-left: 1em; margin-right: 1em;\"><img loading=\"lazy\" decoding=\"async\" border=\"0\" height=\"400\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2010\/02\/AvandiaPost.jpg\" width=\"336\" \/><\/a><\/div>\n<p>\nIt&#8217;s a faux pas to cite an opinion of a physician who was on your payroll as a consultant and speaker. As Ed Silverman over at Pharmalot pointed out, GSK paid Dr. Mintz $11,050 in the first quarter of 2009, something that Forbes originally neglected to point out (see &#8220;<a href=\"http:\/\/www.pharmalot.com\/2010\/02\/a-forbes-guest-blogger-and-his-pharma-ties\/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Pharmalot+%28Pharmalot%29&amp;utm_content=Pageflakes\">A Forbes Guest Blogger And His Pharma Ties<\/a>&#8220;).  <\/p>\n<p>Silverman noted that the Forbes oversight was corrected Monday when Forbes &#8220;placed an editor\u2019s note on blog posts Mintz wrote over the past few days about Avandia and Advair, among other drugs, indicating his ties to various drugmakers.&#8221;<\/p>\n<p>Perhaps Michael F did not see that editor&#8217;s note when he said that Dr. Mintz offered a &#8220;more balanced&#8221; point of view? Or maybe Michael F feels that Dr. Mintz could have a balanced point of view on this subject despite having been on GSK&#8217;s payroll. That could be, but you should not use such a person as your spin poster boy!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GSK continues to use its &#8220;More Than Medicine&#8221; blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see Steve Nissen to GSK (and FDA): &#8220;Put Patients First! It&#8217;s Time to Pull Avandia from the Market.&#8221;). In an early-evening post yesterday, blogger &#8220;Michael F&#8221;, complained of the &#8220;misleading headlines stating [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":9788,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[487,873,191,726],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Geez, GSK! Find Another Source of &quot;Balanced&quot; Commentary - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geez, GSK! Find Another Source of &quot;Balanced&quot; Commentary - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"GSK continues to use its &#8220;More Than Medicine&#8221; blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see Steve Nissen to GSK (and FDA): &#8220;Put Patients First! It&#8217;s Time to Pull Avandia from the Market.&#8221;). In an early-evening post yesterday, blogger &#8220;Michael F&#8221;, complained of the &#8220;misleading headlines stating [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2010-02-23T14:52:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:22:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2010\/02\/AvandiaPost.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"336\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/\",\"url\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/\",\"name\":\"Geez, GSK! Find Another Source of \\\"Balanced\\\" Commentary - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2010-02-23T14:52:00+00:00\",\"dateModified\":\"2019-02-21T01:22:06+00:00\",\"author\":{\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geez, GSK! Find Another Source of &#8220;Balanced&#8221; Commentary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geez, GSK! Find Another Source of \"Balanced\" Commentary - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/","og_locale":"en_US","og_type":"article","og_title":"Geez, GSK! Find Another Source of \"Balanced\" Commentary - Pharma Marketing Network","og_description":"GSK continues to use its &#8220;More Than Medicine&#8221; blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see Steve Nissen to GSK (and FDA): &#8220;Put Patients First! It&#8217;s Time to Pull Avandia from the Market.&#8221;). In an early-evening post yesterday, blogger &#8220;Michael F&#8221;, complained of the &#8220;misleading headlines stating [&hellip;]","og_url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/","og_site_name":"Pharma Marketing Network","article_published_time":"2010-02-23T14:52:00+00:00","article_modified_time":"2019-02-21T01:22:06+00:00","og_image":[{"width":336,"height":400,"url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2010\/02\/AvandiaPost.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/","url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/","name":"Geez, GSK! Find Another Source of \"Balanced\" Commentary - Pharma Marketing Network","isPartOf":{"@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2010-02-23T14:52:00+00:00","dateModified":"2019-02-21T01:22:06+00:00","author":{"@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/geez-gsk-find-another-source-of-more\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Geez, GSK! Find Another Source of &#8220;Balanced&#8221; Commentary"}]},{"@type":"WebSite","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6889"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=6889"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6889\/revisions"}],"predecessor-version":[{"id":9789,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6889\/revisions\/9789"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/9788"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=6889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=6889"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=6889"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=6889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}